Cite
HARVARD Citation
Geldart, T. et al. (n.d.). The use of atezolizumab combination therapy in the EGFR+ metastatic non-squamous NSCLC setting: practical guidance based on early clinical experience. Lung cancer. pp. S48-S49. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geldart, T. et al. (n.d.). The use of atezolizumab combination therapy in the EGFR+ metastatic non-squamous NSCLC setting: practical guidance based on early clinical experience. Lung cancer. pp. S48-S49. [Online].